A authentic DSIP certificate of analysis verifies the structural identity, purity percentage, and endotoxin thresholds of Delta Sleep-Inducing Peptide via RP-HPLC, ESI-MS, and LAL testing. Research institutions rely on lot-specific COAs from accredited facilities to guarantee >99% peptide purity and the absence of bacterial contaminants for reproducible in vitro and preclinical sleep-axis investigations.
A authentic DSIP certificate of analysis verifies the structural identity, purity percentage, and endotoxin thresholds of Delta Sleep-Inducing Peptide via RP-HPLC, ESI-MS, and LAL testing. Research institutions rely on lot-specific COAs from accredited facilities to guarantee >99% peptide purity and the absence of bacterial contaminants for reproducible in vitro and preclinical sleep-axis investigations.
In analytical chemistry and preclinical research, a DSIP certificate of analysis (COA) serves as the primary document establishing the quality, chemical identity, and purity of the neuropeptide Delta Sleep-Inducing Peptide. Because small variations in synthesis can introduce sequence truncation, incomplete deprotection artifacts, or bacterial endotoxins, obtaining a verified lot-specific COA is essential prior to initiating bioassays.
When purchasing compounds through the PX1 Research catalog, every batch undergoes independent validation. Researchers can evaluate key analytical data—including Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) chromatograms, Electrospray Ionization Mass Spectrometry (ESI-MS) spectra, and Chromogenic Limulus Amebocyte Lysate (LAL) endotoxin assays—to confirm that the material meets strict quality criteria required for reproducible laboratory data.
A rigorous dsip certificate of analysis documents specific physicochemical metrics that differentiate research-grade nonapeptides from unverified chemical stock. Laboratory protocols mandate that each batch fulfill distinct criteria across identity, purity, and safety parameters.
The primary analytical criteria documented on a certified PX1 Research COA include:
• Chemical Identity: Verified sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu corresponding to a molecular formula of C35H48N10O15 and exact monoisotopic mass of 848.32 Da. • Chromatographic Purity: Measured via RP-HPLC at 214 nm, requiring ≥98.0% (and typically ≥99.0%) area integration for the primary peptide peak. • Mass Spectrometry Identity: ESI-MS positive ion mode confirming the observed [M+H]+ and [M+2H]2+ ions match theoretical values within ±0.5 Da. • Endotoxin Quantification: Measured via kinetic chromogenic LAL testing, ensuring levels remain strictly below 0.01 EU/mg. • Counterion and Moisture Content: Quantified trifluoroacetate (TFA) residual testing and Karl Fischer titration ensuring consistent dry peptide mass calculation. • Manufacturing Standards: Produced in USA-based, GMP-compliant facilities adhering to ISO 17025 analytical testing protocols.
Each batch ordered for institutional study ships directly from domestic logistics centers in California and Arizona with same-day dispatch for orders finalized before standard cutoff times.
Delta Sleep-Inducing Peptide is an endogenous amphiphilic nonapeptide first isolated from the hemodialysate of rabbits subjected to electrical stimulation of the intralaminar thalamic nuclei. Its primary amino acid sequence is structured as N-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-OH.
Because the N-terminal tryptophan residue contains an indole ring susceptible to oxidative degradation during solid-phase peptide synthesis (SPPS), confirming sequence fidelity via mass spectrometry is critical. A complete DSIP analysis report provides high-resolution ESI-MS spectral output proving the absence of tryptophan-oxidized side products (+16 Da) or deletion sequences missing glycine or alanine residues.
Preclinical investigations demonstrate that DSIP exerts complex neuromodulatory effects on the central nervous system, particularly concerning neuroendocrine stress response and slow-wave EEG architecture. In rodent models, peripheral and central administration of DSIP has been observed to promote delta-wave (0.5–4 Hz) slow-wave sleep activity without inducing non-physiological hypnotic sedation.
In addition to sleep architecture modulation, animal studies indicate that DSIP interacts with the hypothalamic-pituitary-adrenal (HPA) axis. In vitro assays using pituitary cell cultures suggest that DSIP can attenuate basal and stress-induced corticotropin (ACTH) release and modulate plasma corticosterone levels during metabolic or environmental stress protocols. Reviewing the overall DSIP mechanism of action helps researchers map receptor binding profiles against observed physiological outcomes.
When designing preclinical neuroendocrine or stress-axis experimental paradigms, investigators frequently compare DSIP with other synthetic regulatory peptides. The table and detailed analysis below compare DSIP against related research compounds evaluated for central nervous system modulation.
• DSIP (Delta Sleep-Inducing Peptide): A nonapeptide primarily evaluated for delta-wave sleep induction, HPA-axis regulation, and stress-response modulation. • Epitalon: A synthetic tetrapeptide (Epitalon) studied primarily for pineal gland regulation, melatonin synthesis restoration, and telomerase expression in cellular aging models. • Selank: A synthetic heptapeptide derivative of tuftsin (Selank) researched for its anxiolytic properties, BDNF expression modulation, and GABAergic neurotransmission influence. • Semax: An ACTH(4-10) analog (Semax) investigated for its neuroprotective, pro-cognitive, and neurotrophic factor-stimulating mechanisms under ischemic conditions.
While Epitalon influences pineal circadian outputs and Selank targets GABAergic anxiolytic pathways, DSIP uniquely combines slow-wave electroencephalographic synchronization with peripheral stress-axis dampening in animal models. Researchers investigating broader peptide classes can explore our comprehensive research hub for comparative experimental data.
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is the gold standard method for determining the chemical purity of synthetic peptides. In an RP-HPLC analysis, the sample is injected onto a C18 hydrophobic stationary phase and eluted using a binary gradient consisting of water (0.1% TFA) and acetonitrile (0.1% TFA).
When examining a dsip certificate of analysis, researchers should analyze the main chromatographic peak relative to secondary baseline signals. A pure compound shows a sharp, symmetrical peak at the expected retention time (typically between 12 and 18 minutes depending on gradient slope). Minor peaks representing deletion peptides, diastereomers, or incomplete deprotection products must sum to less than 1% total peak area to meet PX1 Research's >99% purity benchmark.
While HPLC quantifies purity percentages, Mass Spectrometry confirms unambiguous molecular identity. ESI-MS ionizes the nonapeptide into protonated species that are separated by their mass-to-charge ratio (m/z).
Because DSIP has a monoisotopic mass of 848.32 Da, positive-mode ESI-MS will yield a predominant singly-charged protonated ion [M+H]+ at m/z 849.32 and a doubly-charged ion [M+2H]2+ at m/z 425.16. The presence of these exact m/z peaks on the lot-specific COA confirms that the primary sequence is intact and correctly assembled without unintended amino acid substitutions.
Bacterial endotoxins (lipopolysaccharides derived from Gram-negative cell walls) pose significant risks in cell culture and animal research models, as microgram quantities can trigger inflammatory cascade responses, pyrexia, and altered cytokine expression that corrupt experimental measurements.
PX1 Research enforces strict endotoxin screening protocols using kinetic chromogenic Limulus Amebocyte Lysate (LAL) assays compliant with USP <85> standards. Every COA issued by our ISO 17025 accredited partner laboratories explicitly states the measured endotoxin level in Endotoxin Units per milligram (EU/mg). Standard research lots maintain levels below 0.01 EU/mg, protecting cell viability in sensitive in vitro electrophysiology and primary cell culture assays.
To preserve chemical integrity after unboxing, researchers must follow standardized laboratory reconstitution protocols for lyophilized peptides. DSIP is supplied as a sterile, lyophilized white powder under vacuum or inert nitrogen atmospheric sealing.
For optimal stability, reconstitute the lyophilized powder using sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4). Allow the vial to equalize to room temperature prior to solvent addition to prevent moisture condensation. Gently swirl the vial without aggressive vortexing, as vigorous agitation can induce shear forces that lead to aggregation of amphiphilic peptides. Detailed reconstitution protocols and molarity calculation tables are accessible via our sleep research peptide guide.
Proper temperature control is critical to prevent peptide hydrolysis and oxidation over extended research timelines. Lyophilized DSIP powder should be stored at -20°C for short-to-medium term storage (up to 24 months) or -80°C for long-term biobanking.
Once reconstituted into aqueous solution, aliquots should be divided into single-use polypropylene microtubes to avoid repeated freeze-thaw cycles. Liquid reconstituted solutions stored at 2°C to 8°C remain stable for up to 30 days when prepared with bacteriostatic agents, whereas aliquoted reconstituted samples kept at -20°C maintain stability for up to 6 months. For extensive technical parameters on temperature handling, consult our guide on neuropeptide stability and storage.
PX1 Research operates as a premier American supplier dedicated exclusively to supporting academic, biotechnology, and institutional research laboratories. By maintaining strict control over synthesis, analytical verification, and climate-controlled storage, we guarantee batch-to-batch consistency across all compound orders.
Principal investigators and laboratory managers seeking bulk procurement options or custom synthesis configurations can submit requests through our dedicated wholesale portal. All shipments are packed in heavy-duty insulated packaging and fulfilled same-day from CA or AZ distribution centers to maintain cold-chain integrity during transit.
What is verified on a DSIP certificate of analysis?
A DSIP certificate of analysis (COA) verifies chemical identity, mass spectrometry molecular weight (848.32 Da), HPLC purity percentage (≥98-99%), bacterial endotoxin quantification (<0.01 EU/mg), TFA counterion content, and physical appearance.
How do I request a lot-specific DSIP certificate of analysis?
Lot-specific COAs for PX1 Research products can be accessed directly on the product page or requested by contacting technical support with the lot number printed on your vial's label.
What purity level is required for DSIP in preclinical research?
Preclinical in vitro and in vivo studies generally require a minimum HPLC purity of ≥98.0%, with premium institutional standards requiring ≥99.0% to prevent non-specific cellular responses from peptide fragments.
What is the theoretical molecular weight shown on a DSIP COA?
The theoretical monoisotopic mass of Delta Sleep-Inducing Peptide (DSIP) is 848.32 Da, with a average molecular weight of approximately 848.81 g/mol.
Why is endotoxin testing critical on a DSIP COA?
Endotoxin testing ensures that the peptide sample contains negligible lipopolysaccharide contaminants (<0.01 EU/mg), preventing unwanted inflammatory cytokine activation or pyrogenic responses in animal models or cell cultures.
How is RP-HPLC used to determine DSIP purity?
Reverse-Phase High-Performance Liquid Chromatography separates the primary nonapeptide from synthetic impurities based on hydrophobicity. Purity is calculated by integrating the area under the primary peak relative to total peak area at 214 nm.
What solvent should be used to reconstitute DSIP for laboratory assays?
Lyophilized DSIP is readily soluble in sterile water, 0.9% normal saline, phosphate-buffered saline (PBS, pH 7.4), or bacteriostatic water containing 0.9% benzyl alcohol for multi-use laboratory procedures.
How should reconstituted DSIP solutions be stored in the lab?
Reconstituted DSIP solutions should be aliquoted into sterile microcentrifuge tubes and stored at -20°C or -80°C to avoid degradation from repeated freeze-thaw cycles. Short-term refrigerated storage (2–8°C) is suitable for up to 30 days when formulated with bacteriostatic preservatives.
What testing facility accreditations back PX1 Research COAs?
PX1 Research COAs are issued by independent ISO/IEC 17025 accredited analytical laboratories utilizing validated RP-HPLC, ESI-MS, and USP <85> kinetic LAL assay methodologies.
Where are PX1 Research DSIP vials manufactured and shipped from?
All PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and shipped directly from dual distribution hubs located in California and Arizona.
Can institutions procure DSIP in bulk quantities for large-scale studies?
Yes, academic and industrial laboratories can arrange bulk procurement, custom batch sizes, and automated reorder schedules through the PX1 Research wholesale portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.